The rating assignment is based on several factors, including Memorial Hermann’s status as a large, $4.8 billion health system with a leading market position and favorable demographics.
The outlook is positive, reflecting Moody’s Investors Service’s expectation that Memorial Hermann will maintain its strong operating margins and liquidity.
Moody’s also assigned “A1/NR” ratings to Memorial Hermann’s proposed series 2016B-1, series 2016B-2, series 2016B-3, series 2016C, series 2016D and series 2016E variable rate bonds.
More articles on healthcare finance:
Fitch assigns ‘A’ rating to Inspira Health’s bonds
Independent emergency group taps McKesson for RCM services
HHS hosts medical bill design contest
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
